Japan's Nikkei hits another new record
TOKYO : Japan's Nikkei rose above 43,000 points for the first time on Wednesday, tracking US stocks which powered to new highs after soft inflation data.
In early trade, the Nikkei 225 index was at 43,062.55, up 0.81%, having already hit a new intraday record high of 42,999 the previous day.
Both the S&P 500 and Nasdaq finished at fresh records on Tuesday after US inflation data showed a still-subdued impact from US President Donald Trump's tariffs.
Investors were also cheered by Trump extending by 90 days a trade truce with China.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
2 hours ago
- Malay Mail
Yuexiu Transport (1052) profit attributable to shareholders increased by 15%
HONG KONG SAR - Media OutReach Newswire - 15 August 2025 - Yuexiu Transport (1052) announced its interim results 2025 and recorded revenue of RMB2.099 billion, representing a year-on-year increase of 14.9%. Profit attributable to shareholders was RMB361 million, an increase of 14.9%. The Company remains committed to maintaining a stable dividend policy with an interim dividend of HK$0.12 per share, equivalent to the payout ratio of 50%.In November 2024, the Company acquired the Pinglin Expressway from its parent company. During the period, this project contributed approximately RMB256 million in toll revenue and approximately RMB42 million in profit attributable. This project is continuously bringing new momentum to the Company's development and benefiting its long-term the first half of 2025, the Company's revenue and profit attributable to shareholders both realized double-digit growth. The Company's 10 subsidiary projects, as a whole, recorded y-o-y growth in both average daily toll revenue and average daily toll traffic volume. The Company further reduced its total liabilities-to-total assets ratio, continued to optimise its financial structure and further extended its debt duration. The total liabilities-to-total assets ratio was 57.9%, dropped by 1.0 percentage point compared to the end of 2024. The weighted average financing rate was 2.57%, down by 0.48 percentage point compared to the first half of Company is committed to becoming a leading transport infrastructure asset management company in China. Guided by its "3331" development strategy, the Company will refine the three platforms (listed platform, REITs platform, incubation platform), enhance the three core abilities (investment ability, operation and maintenance and construction management ability, capital operation ability), and focus on three directions (expressway main business, key areas, expansion of related auxiliary businesses).The Company will firmly grasp the strategic opportunities in expressway investment and mergers and acquisitions. Gaining its foothold in Guangdong, Hong Kong and Macau Greater Bay Area and in Central and Eastern China, the Company will expand its presence in the regions benefiting from urbanisation process and rapid industrialisation development. With the full utilisation of a model that features interaction among its three platforms, the Group continues to strengthen and expand its infrastructure business, with a particular focus on toll #YuexiuTransport The issuer is solely responsible for the content of this announcement.
The Sun
2 hours ago
- The Sun
Trump says will set tariffs on steel and semiconductor chips next week
ABOARD AIR FORCE ONE: U.S. President Donald Trump on Friday said he would set tariffs on imports of steel next week and on semiconductor chips the following week. 'I'll be setting tariffs next week and the week after on steel and on, I would say, chips,' Trump told reporters aboard Air Force One as he headed to a meeting with Russian President Vladimir Putin in Alaska. He said the rates would be lower at the start to allow companies to come and build up domestic manufacturing, rising later. He gave no exact rates - REUTERS
BusinessToday
3 hours ago
- BusinessToday
Private Healthcare Sector Faces Rising Medical Inflation Pressures, CIMB
Malaysia's private healthcare sector is grappling with rising medical inflation and potential structural changes as discussions advance on the adoption of a diagnosis-related group (DRG)–based hospital payment system, according to insights from a recent meeting between CIMB Securities and Datuk Dr Kuljit Singh, President of the Association of Private Hospitals Malaysia (APHM). Private hospitals currently cater to about 30% of Malaysia's patient load—funded primarily through self-payment, personal insurance, and employee benefits—while the public sector supports the remaining 70%. Dr Kuljit highlighted that Malaysia's healthcare quality remains on par with, or better than, many ASEAN peers, sustaining the nation's appeal as a medical tourism hub. Medical Inflation Above Global Average Bank Negara Malaysia (BNM) data shows that medical inflation hit 15% in 2024, surpassing the global average of 10% and the Asia-Pacific average of 11%. Key cost drivers include the adoption of advanced medical technologies, rising medical supply costs, manpower shortages, and overall inflationary pressures. Between 2021 and 2023, claims in the Medical and Health Insurance/Takaful (MHIT) segment surged 73%, outstripping the 21% growth in premiums. Claim frequency more than doubled to 25 per 100 policyholders in 2023 from 11 in 2018. In response, BNM has capped annual premium increases at 10% until the end of 2026, with hikes staggered over three years. Dr Kuljit cautioned that prolonged premium caps could prompt insurers to tighten reimbursement terms and limit hospital or treatment options, potentially curbing investment in private healthcare. To mitigate rising claims, private hospitals are offering negotiated discounts to insurers, which in turn lower out-of-pocket costs for insured patients compared with self-paying patients. Exploring DRG to Curb Costs The proposed DRG system would replace the traditional fee-for-service model with fixed prices for treatments based on case complexity and industry benchmarks. APHM is working with the Ministry of Health to collect and standardise data for a private healthcare DRG database. However, implementation challenges remain due to the lack of a universal healthcare financing framework and comprehensive private-sector data. Globally, DRG models are largely confined to public healthcare systems, with limited adoption in private healthcare. Dr Kuljit noted that complications or additional care beyond the DRG package often create billing and coverage issues in private settings. Sector Outlook CIMB Securities noted that KPJ Healthcare Bhd could be more exposed to DRG-related risks, with 98.1% of its revenue derived locally in 1Q25, compared with IHH Healthcare Bhd's 18–21% Malaysian revenue contribution. The brokerage maintains an Overweight stance on Malaysia's healthcare sector, citing its defensive nature, resilient demand, organic expansion, and favourable demographics. IHH remains its top pick with a Buy rating and a target price of RM8.50, trading at attractive valuations relative to historical and regional averages. KPJ is rated Hold with a TP of RM2.90, as its current share price is seen to have priced in recent operational improvements.
